- Relationship between polymorphisms in homologous recombination repair genes RAD51 G172T、XRCC2 & XRCC3 and risk of breast cancer : A Meta-Analysis.
- Yu J, Wang CG.
- Front Oncol. 2023 Jan 9;12:1047336. doi: 10.3389/fonc.2023.1047336.
- Meta-Analysis
- Free Full Text
- An international, multicentre, real-world analysis of epithelial ovarian cancer treatment and outcomes.
- Cheeseman S, Levick B, Sopwith W, Fenton H, Nam EJ, Kim DK, Lim S, Martin E, FRENEL JS, Bocquet F, Kubelac P, Achimas-Cadariu P, Vlad C, Chevrier M, Rouzier R, Carton M, Savva-Bordalo J, Magalhães M, Borges M, Wolf A, Becker S, Niklas N, Guergova-Kuras M, Hall G.
- Front Oncol. 2023 Jan 9;12:1114435. doi: 10.3389/fonc.2023.1114435.
- January 2023: Awareness of genetic testing – results and analysis from the 2020 Health Information National Trends Survey.
- Genet Med. GenePOD. 2023 Jan 9.
- Podcast
- Free Audio
•• Original research:
Awareness and use of genetic testing: An analysis of the Health Information National Trends Survey 2020.
- PMID: 36136089
- PubMed abstract
- Free Full Texts
- Adding a genetic counseling assistant improves efficiency of hereditary cancer genetic counseling without impacting patient experience.
- Cohen SA, Nixon DM, Lichtenberg E.
- J Genet Couns. 2023 Jan 8. doi: 10.1002/jgc4.1671. Epub ahead of print.
- PMID: 36617522
- PubMed abstract
- Source abstract
- Real-world applications of PARPi maintenance therapy for recurrent ovarian cancer: A single-center study in China.
- Wang DF, Shi XW, Zhang C, Zhang J, Liu H, Huang JM, Zhang GN, Wen QL.
- Gynecol Oncol. 2023 Jan 4;170:25-31. doi: 10.1016/j.ygyno.2022.12.014. Epub ahead of print.
- PMID: 36608384
- PubMed abstract
- Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish Expanded-Access Programme.
- Cueva JF, Palacio I, Churruca C, Herrero A, Pardo B, Constenla M, Santaballa A, Manso L, Estévez P, Maximiano C, Legerén M, Marquina G, de Juan A, Quindós M, Sánchez L, Barquin A, Fernández I, Martín C, Juárez A, Martín T, García Y, Yubero A, Gallego A, Martínez Bueno A, Guerra E, González-Martín A.
- Eur J Cancer. 2023 Jan 1. doi: 10.1016/j.ejca.2022.12.023. Epub ahead of print.
- Circulating T-cell receptor diversity as predictive biomarker for PARP inhibitors maintenance therapy in high grade serous ovarian cancer.
- Shu T, Zhou Z, Bai J, Xiao X, Gao M, Zhang N, Wang H, Xia X, Gao Y, Zheng H.
- Gynecol Oncol. 2023 Jan;168:135-143. doi: 10.1016/j.ygyno.2022.11.013. Epub 2022 Nov 25.
- PMID: 36442424
- PubMed abstract
- Genetic Testing in the Latinx community: Impact of acculturation and provider relationships.
- Ioffe YJ, Hong L, Joachim-Célestin M, Soret C, Montgomery S, Unternaehrer JJ.
- Gynecol Oncol. 2022 Dec 26;169:125-130. doi: 10.1016/j.ygyno.2022.12.001. Epub ahead of print.
- PMID: 36577267
- PubMed abstract
- Source abstract
- Sociodemographic, Clinical, and Variation Outcomes for Breast Cancer and Breast Cancer-Related Mutations in a Ten-Year Cohort From Neiva, Huila, Colombia.
- Olaya J, Sanjuan J, Torres-Lopez D, Olaya L, Gutierrez-Vargas M, Olaya G, Olaya JD.
- Cureus. 2022 Dec 6;14(12):e32257. doi: 10.7759/cureus.32257.
- PMID: 36620844
- PubMed abstract